Current evidence in the stability of medicines in dose administration aids: implications for patient safety

References

• World Health Organization. World report on aging and health. Geneva: World Health Organization; 2015.
   Google Scholar
• Salvi F, Marchetti A, D’Angelo F, et al. Adverse drug events as a cause of hospitalization in older adults. Drug Saf. 2012;35(1):29–45.
   PubMedGoogle Scholar
• World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
   Google Scholar
• Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23.
   PubMed Web of Science ®Google Scholar
• Chiatti C, Bustacchini S, Furneri G, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Saf. 2012;35(1):73–87.
   PubMedGoogle Scholar
• Conn VS, Ruppar TM, Chan KC, et al. Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin. 2015;31(1):145–160.
   PubMed Web of Science ®Google Scholar
• Mahtani KR, Heneghan CJ, Glasziou PP, et al. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011;(9):CD005025.
   PubMed Web of Science ®Google Scholar
• Boeni F, Spinatsch E, Suter K, et al. Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps. Syst Rev. 2014;24(3):29.
   Google Scholar
• Hersberger KE, Boeni F, Arnet I. Dose-dispensing service as an intervention to improve adherence to polymedication. Expert Rev Clin Pharmacol. 2013;6(4):413–421.
   PubMed Web of Science ®Google Scholar
• Gilmartin JF, Hussainy SY, Marriott JL. Medicines in Australian nursing homes: a cross-sectional observational study of the accuracy and suitability of re-packing medicines into pharmacy-supplied dose administration aids. Res Social Adm Pharm. 2013;9(6):876–883.
   PubMed Web of Science ®Google Scholar
• Elliott RA. Appropriate use of dose administration aids. Aust Prescr. 2014;37:46–50.
   Google Scholar
• Gilmartin JF, Raimi-Abraham BT, Jani Y, et al. Taking the guesswork out of supplying multicompartment compliance aids: do pharmacists require further guidance on medication stability? Int J Pharm Pract. 2015;23(5):367–369.
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeia. National Formulary (USP39-NF34). <1191> stability considerations in dispensing practice. Rockville (MD): U.S. Pharmacopeial Convention; 2015.
   Google Scholar
• Pharmaceutical Society of Australia. Guidelines and standards for pharmacists- dose administration aids service. Camberra, Australia: Pharmaceutical Society of Australia; 2007.
   Google Scholar
• Leitlinie der Bundesapothekerkammer zur Qualitätssicherung. Patientenindividuelle manuelle Neuverpackung von Fertigarzneimitteln für bestimmte Einnahmezeitpunkte. Berlin, Germany: Bundesapothekerkammer; 2014. German.
   Google Scholar
• General Council of Pharmaceutical Colleges. Standard operation procedures. Monitored dosage systems. Madrid, Spain: General Council of Pharmaceutical Colleges; 2013. Spanish. Available from: http://www.portalfarma.com/profesionales/organizacionfcolegial/profesionfarma/planfuturofarmaciacomunitaria//Documents/SPD_2013_4.pdf
   Google Scholar
• Royal Pharmaceutical Society. Improving patient outcome- the better use of multi-compartment compliance aids. London, United Kingdom: Royal Pharmaceutical Society; 2013.
   Google Scholar
• Specialist Pharmacist Service. The first stop for professional medicines advice [Internet]. United Kingdom; 2016; [cited 2017 Jul 12]. Available from: www.sps.nhs.uk
   Google Scholar
• Church C, Smith J. How stable are medicines moved from original packs into compliance aids? Pharm J. 2006;276:75–81.
   Google Scholar
• Specialist Pharmacist Service. Usage of medicines on compliance aids [Internet]. United Kingdom; 2016; [cited 2017 Jul 12]. Available from: https://www.sps.nhs.uk/articles/usage-of-medicines-in-compliance-aids/
   Google Scholar
• Haywood A, Glass BD. Evidence of stability of medicines repackaged in compliance aids: a review. Curr Drug Saf. 2016;11(1):69–77.
   PubMed Web of Science ®Google Scholar
• Glass BD, Haywood A, Llewelyn V, et al. Compliance aids and medicine stability: new evidence of quality assurance. Curr Drug Saf. 2009;4(1):74–78.
   PubMedGoogle Scholar
• Haaywood A, Llewelyn V, Robertson S, et al. Dose administration aids: pharmacists’ role in improving patient care. Australas Med J. 2011;4(4):183–189.
   PubMedGoogle Scholar
• Tan JZ, Kwan YH. Stability of chronic medicines in dosage administration aids. How much have been done? Saudi Pharm J. 2016;24(1):21–28.
   PubMed Web of Science ®Google Scholar
• Robertson S, Kockler J, Haywood A, et al. Common medicines for PRN use: stability considerations in DAAs. AJP. 2014;95(1128):56–59.
   Google Scholar
• Gupta A, Ciavarella AB, Rothman B, et al. Stability of gabapentin 300-mg capsules repackaged in unit dose containers. Am J Health-Syst Pharm. 2009;66(15):1376–1380.
   PubMed Web of Science ®Google Scholar
• Haywood A, Mangan M, Glass B. Stability implications of repackaging paracetamol tablets into dose administration aids. J Pharm Pract Res. 2006;36(1):25–28.
   Google Scholar
• Kockler J, Robertson S, Hope D, et al. Stability of paracetamol tablets repackaged in dose administration aids for prn use: implications for practice. J Pharm Pract Res. 2013;43(3):218–220.
   Google Scholar
• Llewelyn VK, Mangan MF, Glass BD. Stability of sodium valproate tablets repackaged into dose administration aids. J Pharm Pharmcol. 2010;62(7):838–843.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gupta A, Carlin AS, et al. Comparative stability of repackaged metoprolol tartrate tablets. Int J Pharm. 2010;385(1–2):92–97.
   PubMedGoogle Scholar
• Loscertales HR, Modamio P, Lastra CF, et al. Stability of enalapril repackaged into monitored dosage system. Curr Med Res Opin. 2015;31(10):1915–1917.
   PubMed Web of Science ®Google Scholar
• Yamazaki N, Iizuka R, Miyazawa S, et al. Selection of generic preparations of famotidine orally disintegration tablets for use in unit-dose packages. Drug Discov Ther. 2012;6(5):263–268.
   PubMedGoogle Scholar
• Elmasry MS, Blagbrough IS, Rowan MG, et al. Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines. J Pharm Biomed Anal. 2011;54(4):646–652.
   PubMed Web of Science ®Google Scholar
• Loscertales HR, Modamio P, Lastra CF, et al. Assessing the stability of lamotrigine dispersible/chewable tablets when stored in blister punch cards. Curr Med Res Opin. 2017;33(5):949–953.
   PubMed Web of Science ®Google Scholar
• Donyai P. Quality of medicines stored together in multi-compartment compliance aids. J Clin Pharm Ther. 2010;35:533–543.
   PubMed Web of Science ®Google Scholar
• Mylrea M, Robertson S, Haywood A, et al. Stability of dispersible aspirin tablets repacked into dosette boxes. J Pharm Pract Res. 2012;42(3):204–207.
   Google Scholar
• The United States Pharmacopeia. National Formulary (USP39-NF34). <671> containers–performance testing. Rockville (MD): U.S. Pharmacopeial Convention; 2016.
   Google Scholar
• The United States Pharmacopeia. National Formulary (USP39-NF34). <1136> packaging and repackaging – single-unit containers. Rockville (MD): U.S. Pharmacopeial Convention; 2016.
   Google Scholar
• Loscertales HR, Modamio P, Braza AJ, et al. Degree of hermeticity of a monitored dosage system. Implications for the quality of medicines and patient safety. Lat Am J Pharm. 2014;33(10):1739–1742.
   Web of Science ®Google Scholar
• Chan K, Swinden J, Donyai P. Pilot study of the short-term physico-chemical stability of atenolol tablets stored in a multi-compartment compliance aid. EJHP Sci. 2007;13(3):60–66.
   Google Scholar
• Bowen L, Mangan M, Haywood A, et al. Stability of frusemide tablets repackaged in dose administration aids. J Pharm Pract Res. 2007;37(3):179–181.
   Google Scholar
• Redmayne N, Robertson S, Kockler J, et al. Repackaged sodium valproate tablets - meeting quality and adherence to ensure seizure control. Seizure. 2015;31:108–111.
   PubMed Web of Science ®Google Scholar
• Perks S, Robertson S, Haywood A, et al. Clozapine repackaged into dose administration aids: a common practice in Australian hospitals. Int J Pharm Pract. 2012;20(1):4–8.
   PubMedGoogle Scholar
• Glass B, Mangan M, Haywood A. Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality? J Clin Pharm Ther. 2009;34(2):161–169.
   PubMed Web of Science ®Google Scholar
• Drovandi AD, Robertson SG, Malau-Aduli BS, et al. Addressing varenicline adherence through repackaging in a dose administration aid. Integr Pharm Res Pract. 2017;6:131–135.
   PubMed Web of Science ®Google Scholar
• Asafu-Adjaye EB, Carlin AS, Jefferson EH, et al. Comparative stability study of unit-dose repackaged furosemide tablets. Clin Res Regul Aff. 2011;28(2):38–48.
   Google Scholar
• Williams R, Roberts M, Riby P, et al. Stability of pharmaceutical products in multi-compartment compliance aids. Int J Pharm Pract. 2010;18(Suppl. 2):93–94.
   PubMedGoogle Scholar
• Wang EH, Bolt JL, Décarie D, et al. Stability of dabigatran etexilate in manufacturer’s blister pack, unit-dose packaging, and community pharmacy blister pack. Can J Hosp Pharm. 2015;68(1):16–21.
   PubMedGoogle Scholar
• Loscertales HR, Modamio P, Lastra CF, et al. Can we repackage omeprazole capsules into multicompartment compliance aids? J Am Geriatr Soc. 2014;62(3):569–570.
   PubMed Web of Science ®Google Scholar